The complete developmental expression pattern of the cyclin dependent kinase inhibitor (CDKI) p57 kip2 has not been reported, here we report a detailed study of the localization of p57 kip2 protein during mouse organogenesis. We show that p57 kip2 is coincident with key stages of differentiation of several organs, some but not all of which are affected in Beckwith-Weidermann syndrome, a human congenital syndrome characterized by foetal overgrowth and childhood tumours. q
Results and discussion
Of the seven mammalian cyclin dependent kinase inhibitor's (CDKI's) the majority are reported to have a tumour suppressor function and all are negative cell cycle regulators (Wagner et al., 1998; Franklin et al., 2000) . p57 kip2 is the only CDKI shown to be required for normal embryogenesis (Zhang et al., 1997; Yan et al., 1997; Takahashi et al., 1997) . Together with p57 kip2 is located within a cluster of imprinted genes on mouse chromosome 7 and human chromosome 11p15 which are associated with embryonic growth regulation in the mouse (DeChiara et al., 1991; Ferguson-Smith et al., 1991) and with Beckwith-Weidemann syndrome (BWS) in humans. Both P57 kip2 and IGF-II, which regulates P57 kip2 protein, are implicated in BWS (Grandjean et al., 2000; Caspary et al., 1999; Hoovers et al., 1995; Ping et al., 1989; Elliot and Maher, 1994; Hu et al., 1997) . Cleft palate, omphalocele, renal medullary dysplasia and adrenal cortical are attributed to the loss of p57 kip2 gene expression (Zhang et al., 1997) .
Antibody specificity and peptide absorption
Staged C57BL10 mouse embryos, were fixed in 4% paraformaldehyde and embedded in paraffin wax . For immunoblotting, embryos were homogenized in a reducing buffer and blotted onto nitrocellulose (Baillie et al., 1996; Grandjean et al., 2000) . Immunostaining as previously described (Smith and Schofield, 1997; Smith et al., 1995; Singh, 1994) . Two goat polyclonal p57 kip2 antibodies (Santa Cruz, USA) were used, M-20 (C-terminal amino acids 305-323) and E-17 (N-terminal amino acids 15-31). Both antibodies gave the same staining pattern and only M-20 is shown. Peptide absorption of the primary antibodies was achieved by incubation (1 h 208C) of diluted antibody with concentrations of M-20 peptide between 20 and 500 mg/ml (Fig. 1 ).
Protein localization of P57 kip2

P57
kip2 is in derivatives of all three germ layers, the endoderm, mesoderm and ectoderm and in all major organs of the body during key stages of their genesis. It is predominantly in the nucleus, as expected from a CDKI. Cytoplasmic staining is present in skeletal muscle tissues at later stages but at a lower intensity than seen in muscle nuclei (Fig. 2) . In the embryo p57 kip2 is found earliest (E10.5) in the heart ( Fig. 2A) . At E11.5 P57 kip2 stains neural tissues, Rathke's pouch and the infundibulum, which become the pituitary, and some cells of the dorsal brain ( Fig. 3A-E ). P57 kip2 staining is intense and widespread at E13.5 and present in cells of the heart and skeleto-muscular system, neural system (including choroid plexus), parenchymal organs (e.g. lung and kidney) and in extraembryonic tissues . Staining declines sharply in all tissues after E13.5, except in skeletal muscle where staining persists at relatively high levels to E17.5 (Fig. 2 ).
Musculo-skeletal system
At E13.5 p57 kip2 is in chondrocytes located in proliferative regions of the developing bone, there is gradual loss of p57 kip2 throughout development until it is restricted to the hypertrophic zone (Fig. 2E,F) . It is suggested that p57 kip2 is required to complete chondrocyte differentiation (Zhang et al., 1997; Yan et al., 1997; Takahashi et al., 1997) .
At E13.5 p57 kip2 is in all skeletal muscles, mainly restricted to those cells which are not terminally differentiated as cells with p57 kip2 positive nuclei do not contain muscle myosins (data not shown). As reported, p57 kip2 persists in some but not all nuclei in skeletal muscles until E17.5. At E15.5 we observe patchiness in muscle fibre staining (Fig. 2H,I ). At kip2 (M-20) staining in E13.5 embryonic lung bronchiole (br) epithelium cells (arrow) and in rib (rib) cartilage chondrocytes. Weak staining in lung interstitial cells. For immunstaining embryo sections were pre-blocked with hydrogen peroxidase solution (0.5% H 2 O 2 in tap water, 1 h) and subject to 2 min pressure cooking in sodium citrate buffer (Singh, 1994; Smith and Schofield, 1997) . Primary antip57 kip2 antibody (M-20, from Santa Cruz, USA) was applied at a dilution of 1/1000. In all experiments adjacent sections were incubated with biotinylated second antibody (Amersham, 1/1000) alone and were always unstained. Detection was with vector elite (vectastains) and visualization with DAB (Dakopatt).
Counterstain was Gills haemotoxylin (BDH, UK). (B) p57
kip2 staining in lung is abolished following peptide absorption of the M-20 antibody with M-20 peptide (1/200 dilution). Section was adjacent to that shown in (A), almost all staining has been inhibited with only faint staining seen in some lung epithelial cells (arrow) which express p57 kip2 most strongly. The same substantial inhibition of p57 kip2 staining was observed, following peptide absorption of the antibody, in all of the tissues described in this paper including cytoplasmic staining of cardiac and skeletal muscle tissues (data not shown). (C) p57 kip2 M-20 antibody detects a single 57 kDa protein following whole embryo (E13.5) western blotting. Similar data (not shown) was obtained for the E17 antibody. kip2 is expressed in approximately 50% of skeletal muscle cells at E17.5. Staining is predominantly nuclear but weaker cytoplasmic staining is also seen. (I) by E15.5 p57 kip2 expression is restricted in cartilage, absent from the perichondrium (Pch) and expressed patchily in skeletal muscles (Skm) particularly the abdominal body wall muscles (AbM). Magnification £ 63 (J) p57 kip2 is expressed in nuclei and cytoplasm of some body wall muscles (arrows) but not in others. Magnification £ 630.
E17.5 p57
kip2 is predominantly cytoplasmic, and may be nonfunctional (Matsuoka et al., 1995; Reynaud et al., 2000) , however nuclei in some newly formed muscle fibres are also strongly positive for p57 kip2 , on maturation these nuclei disperse to the myofibre edge (Fig. 3J ).
Parenchymal organs p57
kip2 staining is in all parenchymal organs and is particularly evident at E13.5 in gonad, thyroid, parathyroid, thymus, adrenal gland, pancreas, kidney and lung kip2 in parenchymal organs is most evident at E13.5 and is seen in (A) presumptive sertoli cell precursors (se) in the testes as well as in interstitial mesenchymal cells in the pancreas (p). Magnification £ 160. By E14.5 p57 kip2 in the testes is restricted to a few cells dividing the gonad from the developing kidney. At E13.5 p57 kip2 is in mesenchyme (m) and the proximal duct (pd) region in the thyroid. (B,C) P57 kip2 staining in the E13.5 adrenal is complex and seen in some but not all cells of both epithelial (duct) and interstitial layers. (B) magnification £ 160. (C) p57 kip2 is in a mitotic cell (m, indicated by arrow) in the developing adrenal gland, magnification x 630. In the developing ear (D,E). (D) At E13.5 p57 kip2 stains strongly the epithelial cells of the semicircular canals (Scc). p57 kip2 is particularly strong at the inside corners (arrows) of the posterior (pScc) and anterior semicircular canals of the inner ear, magnification £ 160. (E) By E17.5 there is no p57 kip2 in the inner ear and semicircular canal (Scc), magnification £ 63. (F) During nasal cavity (nc) development (E13.5) p57 kip2 is strongest in cells of the olfactory epithelium (OE) and the cartilage primordia of the turbinate bones (TBp), magnification £ 160. (G,H) p57 kip2 staining is complex in the cusp stage tooth bud and in early stages (G) strongly staining in the ectomesenchyme (EcM) and the majority of mesenchymal (M) cells surrounding the emerging tooth. In epithelium (Ep) p57 kip2 is restricted to thickened marginal regions, magnification £ 250. (H) p57 kip2 is not in the enamel knot (EK) but stains weakly in some cells in the pre-odondoblast (PO) layer. Once the cusp is formed staining in mesenchymal (M) cells diminishes, magnification £ 160. At E13.5 p57 kip2 is strong in the endodermal layer (En) of the gut and stomach and weak in cells of the epithelial cells (Ep) surrounding the lumen (lu) and in the mesenchyme. (I) Endodermal cell staining is very evident in the E13.5 omphalocele, magnification £ 160. (J) E17.5 p57 kip2 in the colon is restricted to epithelial villi cells, magnification £ 160, some of which appear rounded and pyknotic (arrow) and may be undergoing apoptosis. . At E13.5 p57 kip2 is also evident in the cerebellum, (F) the choroid plexus, the developing eye, particularly retina (R) and (G) the leptomeninges (lm), all at magnification £ 160. (K) By E13.5 p57 kip2 is not present in dorsal root ganglia (drg), magnification £ 160. 6). All these organs show a dynamic p57 kip2 pattern declining rapidly after E13.5. In lung, kidney and gonad there is strong gradation in the intensity of staining of different cell layers (Figs. 4A-C, 5 and 6). We examined two of these organs (kidney and lung) in detail. Both show a temporal peak of p57 kip2 , which declines in later embryonic stages.
1.4.1. Kidney p57 kip2 staining peaks in developing kidney at E13.5 ( Fig.  5A-C) . In the medullar is a dynamic pattern of strongly stained interstitial stromal mesenchymal cells adjacent to more weakly stained epithelial tubules. High levels of p57 kip2 staining are in the leading edge cells of developing proximal tubules. Highest levels are in condensed eptheliarizing cells at the tips of these tubules (Fig. 5B,C) . At E15.5, staining is almost absent in cortex, but there is strong staining of some intersitial mesenchymal cells in the medullar (Fig. 4D) . Staining is weak at E17.5 except for in proximal convoluted tubules where there is strongly positive cell debris and several p57 kip2 positive pyknotic cells, under- kip2 . These cells may be undergoing apoptosis. kip2 staining and which are placed at the corners of extending bronchioles. Cells of the mesenchymal stroma overlying cuboidal epithelium also stain for p57 kip2 , magnification £ 250. (E) p57 kip2 levels are very much reduced by E15.5 and restricted to columnar cells of the segmental (SBr) and terminal bronchi. Alveoli (al) are not p57 kip2 positive. Magnification £ 160. (F) By E17.5 p57 kip2 has disappeared, in contrast to the strong staining still evident in the diaphragm (dia). P57 kip2 is also absent from the liver (Li). Magnification £ 160.
going apoptosis (Fig. 4E,F) . Reduction of the distal convoluted tubule is mediated by apoptosis (Coles et al., 1993) . p57 kip2 is associated with apoptosis in cleft palate (Yan et al., 1997) , retina (Zhang et al., 1997) and possibly colon (Fig. 4L ) and limb bud (Fig. 7) .
Lung
In lung p57 kip2 is in columnar cells of the major and segmental bronchi (Fig. 6A-D) . There is a striking absence of p57 kip2 in those cells of the bronchiole epithelium which have differentiated and become cuboidal. P57 kip2 is present in mesenchymal cells underlying these cuboidal cells (Fig.  6C,D) . After E13.5 p57 kip2 fades from all lung cells (Fig.  6E,F) .
Both kidney and lung tissues show gradation of p57 kip2 intensity in different cell types. In Xenopus eye, overexpression of the p57 kip2 homologue p27 Xic1 , inhibits proliferation in retina cells and initiates premature differentiation of Muller cells. Here cell fate is thought to be determined by the level of expression of p27
Xic1 (Ohnuma et al., 1999) . All parenchymal organs are induced by epithelialmesenchymal interactions. Some parenchymal organs (e.g. thymus, parathyroid and thyroid glands) also have a neural crest component. p57 kip2 staining in these tissues reflects that seen in the less complex parenchymal organs. p57 Kip2 is strongly expressed in stromal cells surrounding forming ducts and in the cells at the tips of these ducts where they make contact with cells from the underlying mesenchyme. p57 kip2 is not in the central elongated portions of the thryoid duct. Similar, but more complex inductions are also seen in the inner ear, nose and primordial tooth bud (Fig. 3D-J) . p57 kip2 is in all tissues layers but is strongest where these layers meet.
Intestinal tract
P57
kip2 is in all three layers of the gut and stomach, although intensity of staining and the proportion of p57 kip2 positive cells varies. Both are greatest in the endothelial (smooth muscle) layer and least strong in the mesothelium (Fig. 4K,L) . In stomach p57 kip2 is predominant in the smooth muscle layer. Intense p57 kip2 staining in the gut and adjacent abdominal wall muscles (see Fig. 2I ) is of interest because absence of p57 kip2 is implicated in the failure of the omphalocele to be incorporated into the gut cavity in BWS (Zhang et al., 1997 ).
Developing limb p57
kip2 is evident in E11.5 limb bud. Epithelial staining is restricted to the apical ectodermal ridge (AER) which maintains proximal-distal elongation of the limb and disappears by E13.5 (Fig. 7A,B) . Mesenchymal staining is widespread. A band of cells directly beneath the AER at the distal tip of the limb bud are negative for p57 kip2 . These cells overlap with, the cells of the progress zone (PZ) where the majority of mitotic division is taking place. By E15.5 the pattern is more restricted with p57 kip2 in alternating layers, defining a region between the digits where programmed cell death occurs during digitalization (Fig. 7C,D) . A group of cells in this region, undergoing apoptosis (A), are not stained for p57 kip2 . At the most distal tip of each digit are a small ball of cells which do not stain for p57 kip2 (Fig. 7E,F) . A similar band of p57 kip2 positive cells, separated by a layer of p57 kip2 negative cells, define the end of the tail (not shown). By E17.5 this outer line of p57 kip2 positive cells has disappeared.
Extraembryonic tissues
p57
kip2 is in the embryonic component of the decidua as early as E8.5 but is not seen in the maternal components, with the exception of a few scattered cells. By E13.5 expression of p57 kip2 is more widespread and in cells of all layers of the developing placenta. p57 kip2 persists throughout pregnancy in placental tissues and extraembryonic membranes. Trophoblastic giant cells express p57 kip2 very strongly ( Fig.  8A-H) . In normal embryos 50% of cells of the epithelial layer of the yolk sac and the amnion are strongly p57 kip2 positive. In chromosome 7 maternal disomy (MatDi7) mutants IGF-II is not expressed and p57 kip2 is overexpressed (Ferguson-smith et al., 1991; Grandjean et al., 2000) . Eighty to ninety percent of cells in MatDi7 extraembryonic membranes have strong p57
Kip staining.
Conclusion
In some tissues p57 kip2 is present in a proportion of cells consistent with a cell cycle regulator. However, in many tissues p57 kip2 is seen in groups of cells which are not terminally differentiated but which are undergoing shape changing (e.g. pituitary infundibulum, lung columnar cells, kidney). In others (adrenal, progress zone of the limb bud) p57 kip2 is associated with dividing cells and is even present in mitosing cells. p57 kip2 is found in cells of all of the tissues affected in BWS including those tissues where Igf2 is also implicated. There are also organs, such as the gonads, lungs, and the brain, in which p57 kip2 is located during development, but which are not affected in BWS. Of these only the brain and pituitary have been reported to develop normally in the p57 kip2 deficient mouse. Most p57 kip2 null mutants die around the time of birth with 'breathing difficulties' (Zhang et al., 1997) , those few (10%) which survive longer have gonadal defects (Takahashi et al., 1997) .
